Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Politi

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Molecular Pharmacology|June 1, 1990
P-glycoprotein-independent mechanism of resistance to VP-16 in multidrug-resistant tumor cell lines: pharmacokinetic and photoaffinity labeling studiesP M Politi, S T Arnold, R L Felsted, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Structure-activity relations, cytotoxicity and topoisomerase II dependent cleavage induced by pendulum ring analogues of etoposideB K Sinha, P M Politi, H M Eliot, et al.
Cancer Treatment Reports|February 1, 1985
Vinca alkaloid-induced cardiovascular autonomic neuropathyE Roca, E Bruera, P M Politi, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1992
AntimetabolitesE Chu, J L Grem, P G Johnston, et al.
Medicina|January 1, 1983
[The electrocardiogram in the prediction of the pathology of chronic coronary cardiopathy]A M Perosio, L D Suárez, P M Politi, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1993
AntimetabolitesE Chu, P G Johnston, C H Takimoto, et al.
Molecular Pharmacology|August 1, 1995
Determinants of sensitivity to 1-beta-D-arabinofuranosylcytosine in HCT 116 and NCI-H630 human colon carcinoma cellsJ L Grem, F Geoffroy, P M Politi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Phase I clinical trial of continuous infusion cyclopentenyl cytosineP M Politi, F Xie, W Dahut, et al.
Biochemical Pharmacology|June 28, 1996
Cytotoxicity and DNA damage associated with pyrazoloacridine in MCF-7 breast cancer cellsJ L Grem, P M Politi, S L Berg, et al.
Seminars in Oncology|November 5, 1997
Paclitaxel in platinum-resistant ovarian cancer patients. Argentine Multicenter Taxol GroupL Ezcurdia, S L Jovtis, E Mickiewicz, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Molecular Pharmacology|June 1, 1990
P-glycoprotein-independent mechanism of resistance to VP-16 in multidrug-resistant tumor cell lines: pharmacokinetic and photoaffinity labeling studiesP M Politi, S T Arnold, R L Felsted, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Structure-activity relations, cytotoxicity and topoisomerase II dependent cleavage induced by pendulum ring analogues of etoposideB K Sinha, P M Politi, H M Eliot, et al.
Cancer Treatment Reports|February 1, 1985
Vinca alkaloid-induced cardiovascular autonomic neuropathyE Roca, E Bruera, P M Politi, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1992
AntimetabolitesE Chu, J L Grem, P G Johnston, et al.
Medicina|January 1, 1983
[The electrocardiogram in the prediction of the pathology of chronic coronary cardiopathy]A M Perosio, L D Suárez, P M Politi, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1993
AntimetabolitesE Chu, P G Johnston, C H Takimoto, et al.
Molecular Pharmacology|August 1, 1995
Determinants of sensitivity to 1-beta-D-arabinofuranosylcytosine in HCT 116 and NCI-H630 human colon carcinoma cellsJ L Grem, F Geoffroy, P M Politi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Phase I clinical trial of continuous infusion cyclopentenyl cytosineP M Politi, F Xie, W Dahut, et al.
Biochemical Pharmacology|June 28, 1996
Cytotoxicity and DNA damage associated with pyrazoloacridine in MCF-7 breast cancer cellsJ L Grem, P M Politi, S L Berg, et al.
Seminars in Oncology|November 5, 1997
Paclitaxel in platinum-resistant ovarian cancer patients. Argentine Multicenter Taxol GroupL Ezcurdia, S L Jovtis, E Mickiewicz, et al.
Pageof 2